Sagimet Biosciences Inc.
SGMTBiotechnology
$10.43−2.89%As of Oct 29vs prior close
- Market cap
- $739.6M
- P/E (TTM)
- –
- From 52W high
- −6.62%
- EPS (LTM)
- -$1.29
- Revenue (YE23)
- $2M
- Dividend yield
- 0.00%
Nomior Score
47
Steady ProfileSpeculativeBottom 43% of the scored universe
Growth—
Quality53
Value—
Momentum53
Resilience39
Connections
Revenue to profitQ3 YE23
The operating loss was 373% of revenue.
Who owns it
2funds, 1 tracked portfolio